A 59 year old African American woman presents with the following lesion. She states she is currently applying topical clobetasol and takes oral hydroxychloroquine, prednisone, and mycophenolate daily. She is interested in discussing ways to improve the appearance of this lesion. Which of the following is NOT true?
A. Patient should contine with strict photoprotection given the photosensitive nature of her disease
B. Patient can undergo treatment with pulsed dye laser and Q-switched neodymium-doped yttrium aluminum garnet or for lesions that remain active despite medical management
C. Fat transfer for atrophic lesions can be performed when disease is inactive and patient is off immunosuppressive medications
D. Systemic prednisone is associated with poorer outcomes after fat transfer
E. Disease reactivation after reconstructive filler injection is high
